D J Wallace Selected Research

abetimus

1/2004	LJP 394 (abetimus sodium, Riquent) in the management of systemic lupus erythematosus.
1/2003	Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.
1/2001	Clinical and pharmacological experience with LJP-394.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D J Wallace Research Topics

Disease

26	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2000
3	Fatigue 08/2017 - 07/2001
3	Arthritis (Polyarthritis) 08/2017 - 02/2000
3	Rheumatoid Arthritis 08/2017 - 01/2000
3	Exanthema (Rash) 08/2017 - 02/2000
2	Neoplasms (Cancer) 01/2018 - 02/2013
2	Autoimmune Diseases (Autoimmune Disease) 06/2014 - 05/2011
2	Hypersensitivity (Allergy) 02/2013 - 01/2002
2	Infections 02/2013 - 05/2011
2	Lupus Nephritis 01/2004 - 01/2001
1	Opioid-Related Disorders (Opiate Addiction) 10/2020
1	Poisoning 10/2020
1	Substance-Related Disorders (Drug Abuse) 10/2020
1	Vitamin D Deficiency 08/2018
1	Discoid Lupus Erythematosus 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Heart Arrest (Cardiac Arrest) 03/2014
1	Takotsubo Cardiomyopathy 03/2014
1	Skin Neoplasms (Skin Cancer) 02/2013
1	Melanoma (Melanoma, Malignant) 02/2013
1	Psychotic Disorders (Schizoaffective Disorder) 10/2011
1	Intracranial Thrombosis (Cerebral Thrombosis) 10/2011
1	Serositis 05/2011
1	Body Weight (Weight, Body) 10/2010
1	Pericarditis 10/2010
1	Pleurisy (Pleuritis) 10/2010
1	Disease Progression 05/2009
1	Pre-Eclampsia (Preeclampsia) 01/2007
1	Hemolysis 01/2007
1	Chronic Renal Insufficiency 01/2007
1	Drug Hypersensitivity (Drug Allergy) 01/2002
1	Pain (Aches) 07/2001
1	Fibromyalgia (Fibrositis) 07/2001
1	Necrosis 07/2001
1	Hyperalgesia 07/2001
1	Hemorrhage 01/2001
1	Diarrhea 01/2001
1	Cryoglobulinemia 01/2001
1	Reactive Arthritis (Reiter Disease) 02/2000
1	Urethritis 02/2000
1	Conjunctivitis 02/2000
1	Rheumatic Diseases (Rheumatism) 01/2000
1	Nephritis 01/2000
1	Proteinuria 01/2000

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 09/2017 - 04/2001
6	AntibodiesIBA 08/2017 - 01/2000
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2004
3	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 01/2000
3	abetimusIBA 01/2004 - 01/2001
2	C-Reactive ProteinIBA 08/2017 - 05/2011
2	epratuzumabIBA 04/2016 - 04/2013
2	Immunoglobulin G (IgG)IBA 02/2016 - 01/2001
2	Monoclonal AntibodiesIBA 02/2016 - 04/2013
2	EnzymesIBA 01/2007 - 01/2000
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2020
1	hydroxide ionIBA 10/2020
1	Prednisone (Sone)FDA LinkGeneric 08/2018
1	Janus KinasesIBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Syk KinaseIBA 01/2018
1	R333IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	tabalumabIBA 02/2016
1	B-Cell Activating FactorIBA 02/2016
1	Excipients (Suspending Agents)IBA 06/2014
1	belimumabIBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 10/2011
1	Prostaglandins AIBA 01/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Abatacept (Orencia)FDA Link 10/2010
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2009
1	SolutionsIBA 02/2009
1	Testosterone (Sustanon)FDA Link 03/2008
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2008
1	AndrogensIBA 03/2008
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2002
1	Celecoxib (Celebrex)FDA Link 01/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2002
1	Immunomodulating AgentsIBA 08/2001
1	Biological ProductsIBA 08/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2001
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2001
1	Interleukin-6 (Interleukin 6)IBA 07/2001
1	Interleukin-8 (Interleukin 8)IBA 07/2001
1	Interleukin-10 (Interleukin 10)IBA 07/2001
1	Interleukin-2 (IL2)IBA 07/2001
1	Interferon-gamma (Interferon, gamma)IBA 07/2001
1	CytokinesIBA 07/2001
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2001
1	thiamine triphosphorate (TTP)IBA 01/2001
1	Leflunomide (Arava)FDA LinkGeneric 01/2001
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2000
1	Serum AlbuminIBA 01/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2000

Therapy/Procedure

6	Therapeutics 04/2016 - 01/2001
1	Liver Transplantation 03/2014
1	Blood Component Removal (Apheresis) 04/2001